Sapient
Sapient Bioanalytics is a leading multi-omics biomarker discovery company specializing in proteomics, metabolomics, and lipidomics services to accelerate precision drug development. The company leverages high-throughput mass spectrometry and advanced AI-driven biocomputational analysis through its proprietary DynamiQ™ Insights Engine, which integrates multi-omics data with real-world clinical data from over 56,000 human samples. Sapient's platform enables discovery, translational, and clinical applications by identifying novel drug targets, robust biomarkers, and clinical signatures of drug response. Their services include discovery proteomics with coverage of thousands of proteins, targeted protein assays, metabolite and lipid panels, cytokine and chemokine assays, and comprehensive data analysis to de-risk drug development and optimize clinical trial success. Sapient operates a CLIA-certified, CAP-accredited lab, supporting rapid translation of discoveries to clinical diagnostics and companion diagnostics development. Founded by members of the Jain Lab at UC San Diego, Sapient has received significant funding including grants from the Bill & Melinda Gates Foundation, positioning it as a major player in the biomarker discovery and drug development ecosystem.
Sapient
Sapient Bioanalytics is a leading multi-omics biomarker discovery company specializing in proteomics, metabolomics, and lipidomics services to accelerate precision drug development. The company leverages high-throughput mass spectrometry and advanced AI-driven biocomputational analysis through its proprietary DynamiQ™ Insights Engine, which integrates multi-omics data with real-world clinical data from over 56,000 human samples. Sapient's platform enables discovery, translational, and clinical applications by identifying novel drug targets, robust biomarkers, and clinical signatures of drug response. Their services include discovery proteomics with coverage of thousands of proteins, targeted protein assays, metabolite and lipid panels, cytokine and chemokine assays, and comprehensive data analysis to de-risk drug development and optimize clinical trial success. Sapient operates a CLIA-certified, CAP-accredited lab, supporting rapid translation of discoveries to clinical diagnostics and companion diagnostics development. Founded by members of the Jain Lab at UC San Diego, Sapient has received significant funding including grants from the Bill & Melinda Gates Foundation, positioning it as a major player in the biomarker discovery and drug development ecosystem.